Immunome. Every tracked FinTwit mention of $IMNM, newest first. 12 mentions since the first on Nov 28, 2025. See the price chart.
May 2026 · 2 mentions
May 30
Jacob Plieth — So anything actually new in $IMNM's Ringside presentation that we didn't already know in December? Apparently it's good enough for #Asco26↗
May 21
Jacob Plieth — $PBLS data at #ESMO25. cc $MKGAF $IMNM↗
December 2025 · 9 mentions
Dec 15
Jacob Plieth — Knockout data for $IMNM. What now? Via @ApexOnco -> https://t.co/eh1j0iFAR1↗
Dec 15
Jacob Plieth — God help $IMNM if they try a solo launch https://t.co/aw97pHB2HY↗
Dec 15
Jacob Plieth — Important safety consideration for $IMNM. Remember ovarian tox is a warning on Ogsiveo's label https://t.co/nKxMxCkUwo↗
Dec 15
Jacob Plieth — @phoenicianstrat @a_a_free So Ogsiveo 2024 sales $172m, tracking for ~$260m in 2025? It's a good Q $IMNM↗
November 2025 · 1 mention
Nov 28
Jacob Plieth — $1.7bn valuation, stock +75% YTD, $IMNM eyes $SWTX's success. What does varegacestat need to hit in Ringside? Via @ApexOnco -> https://t.co/PsBMmjBQnS↗
Dec 15
Jacob Plieth — Goodnight Vienna $IMNM https://t.co/vZngGCe41r↗
Jacob Plieth — Hopefully $IMNM will show us the PFS curves. HR=0.16 seems pretty amazing (Ogsiveo scored HR=0.29 vs placebo in Defi) https://t.co/98MuF98AVi↗
Dec 15
Jacob Plieth — 56% ORR clears the 50% bull case scenario, and looks better than Ogsiveo's 41% in Defi. Below the 64% it scored in phase 2, obviously $IMNM↗
Dec 15
Jacob Plieth — Data coming today at 7:30am ET $IMNM↗